Skip to main content
Top
Published in: Abdominal Radiology 10/2020

01-10-2020 | Prostate Cancer | Pelvis

Apical periurethral transition zone lesions: MRI and histology findings

Authors: Sena Tuncer, Sherif Mehralivand, Stephanie A. Harmon, Thomas Sanford, G. Thomas Brown, Lindsay S. Rowe, Maria J. Merino, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke, Baris Turkbey

Published in: Abdominal Radiology | Issue 10/2020

Login to get access

Abstract

Purpose

Apical periurethral transition zone (TZ) cancers can pose unique problems for surgery and radiation therapy. Here, we describe the appearance of such cancers on multiparametric MRI (mpMRI) and correlate this with histopathology derived from MRI-targeted biopsy.

Materials and methods

Between May 2011 and January 2019, a total of 4381 consecutive patients underwent 3 T mpMRI. Of these, 53 patients with 58 apical periurethral TZ lesions underwent TRUS/MRI fusion-guided biopsy and 12-core systematic TRUS-guided biopsy. Correlation was made with patient age, PSA, PSA density, whole prostate volume, and Gleason scores.

Results

A total 53 men (median age 68 years, median PSA 7.94 ng/ml) were identified as having at least one apical periurethral TZ lesion on mpMRI and 5 (9%) patients had more than one apical periurethral lesion. Thus, 58 lesions were identified in 53 patients. Of these 37/53 patients (69%) and 40/58 lesions were positive at biopsy for prostate cancer. Seven were diagnosed by 12-core systematic TRUS-guided biopsy and 34 were diagnosed by TRUS/MRI fusion-guided biopsy. Gleason score was ≥ 3 + 4 in 34/58 (58%) lesions.

Conclusion

Identification of apical periurethral TZ prostate cancers is important to help guide surgical and radiation therapy as these tumors are adjacent to critical structures. Because of the tendency to undersample the periurethral zone during TRUS biopsy, MRI-guided biopsy is particularly helpful for detecting apical periurethral TZ prostate cancers many of which prove to be clinically significant.
Literature
2.
go back to reference Mertan FV, Greer MD, Shih JH, George AK, Kongnyuy M, Muthigi A, Merino MJ, Wood BJ, Pinto PA, Choyke PL et al: Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection. J Urol 2016, 196(3):690-696.CrossRef Mertan FV, Greer MD, Shih JH, George AK, Kongnyuy M, Muthigi A, Merino MJ, Wood BJ, Pinto PA, Choyke PL et al: Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection. J Urol 2016, 196(3):690-696.CrossRef
3.
go back to reference Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM et al: Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015, 313(4):390-397.CrossRef Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM et al: Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015, 313(4):390-397.CrossRef
4.
go back to reference Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA: Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int 2012, 110(11 Pt B):E694-700. Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA: Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int 2012, 110(11 Pt B):E694-700.
5.
go back to reference Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA: Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int 2014, 114(6b):E43-E49.CrossRef Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA: Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int 2014, 114(6b):E43-E49.CrossRef
6.
go back to reference Sankineni S, George AK, Brown AM, Rais-Bahrami S, Wood BJ, Merino MJ, Pinto PA, Choyke PL, Turkbey B: Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsy. Abdom Imaging 2015, 40(7):2557-2565.CrossRef Sankineni S, George AK, Brown AM, Rais-Bahrami S, Wood BJ, Merino MJ, Pinto PA, Choyke PL, Turkbey B: Posterior subcapsular prostate cancer: identification with mpMRI and MRI/TRUS fusion-guided biopsy. Abdom Imaging 2015, 40(7):2557-2565.CrossRef
7.
go back to reference Numao N, Kawakami S, Sakura M, Yoshida S, Koga F, Saito K, Masuda H, Fujii Y, Yamamoto S, Yonese J et al: Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU Int 2012, 109(5):665-671.CrossRef Numao N, Kawakami S, Sakura M, Yoshida S, Koga F, Saito K, Masuda H, Fujii Y, Yamamoto S, Yonese J et al: Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy. BJU Int 2012, 109(5):665-671.CrossRef
8.
go back to reference PIRADS version 2 American Collage of Radiology. 2015. PIRADS version 2 American Collage of Radiology. 2015.
9.
10.
go back to reference McNeal JE: The prostate and prostatic urethra: a morphologic synthesis. J Urol 1972, 107(6):1008-1016.CrossRef McNeal JE: The prostate and prostatic urethra: a morphologic synthesis. J Urol 1972, 107(6):1008-1016.CrossRef
11.
go back to reference McNeal JE: Regional morphology and pathology of the prostate. Am J Clin Pathol 1968, 49(3):347-357.CrossRef McNeal JE: Regional morphology and pathology of the prostate. Am J Clin Pathol 1968, 49(3):347-357.CrossRef
12.
go back to reference Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ: Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997, 158(6):2168-2175.CrossRef Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ: Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997, 158(6):2168-2175.CrossRef
13.
go back to reference Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbo HB, Ukimura O: A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016, 69(1):149-156.CrossRef Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbo HB, Ukimura O: A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016, 69(1):149-156.CrossRef
14.
go back to reference Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M: The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 2015, 350:h2147.CrossRef Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M: The PRECIS-2 tool: designing trials that are fit for purpose. BMJ 2015, 350:h2147.CrossRef
15.
go back to reference Vargas HA, Akin O, Franiel T, Goldman DA, Udo K, Touijer KA, Reuter VE, Hricak H: Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. Radiology 2012, 262(3):894-902.CrossRef Vargas HA, Akin O, Franiel T, Goldman DA, Udo K, Touijer KA, Reuter VE, Hricak H: Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. Radiology 2012, 262(3):894-902.CrossRef
16.
go back to reference Thai JN, Narayanan HA, George AK, Siddiqui MM, Shah P, Mertan FV, Merino MJ, Pinto PA, Choyke PL, Wood BJ et al: Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer. Radiology 2018, 288(2):485-491.CrossRef Thai JN, Narayanan HA, George AK, Siddiqui MM, Shah P, Mertan FV, Merino MJ, Pinto PA, Choyke PL, Wood BJ et al: Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer. Radiology 2018, 288(2):485-491.CrossRef
17.
go back to reference Matta R, Chapple CR, Fisch M, Heidenreich A, Herschorn S, Kodama RT, Koontz BF, Murphy DG, Nguyen PL, Nam RK: Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review. Eur Urol 2019, 75(3):464-476.CrossRef Matta R, Chapple CR, Fisch M, Heidenreich A, Herschorn S, Kodama RT, Koontz BF, Murphy DG, Nguyen PL, Nam RK: Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review. Eur Urol 2019, 75(3):464-476.CrossRef
18.
go back to reference Marigliano C, Donati OF, Vargas HA, Akin O, Goldman DA, Eastham JA, Zelefsky MJ, Hricak H: MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer. Eur J Radiol 2013, 82(12):e775-781.CrossRef Marigliano C, Donati OF, Vargas HA, Akin O, Goldman DA, Eastham JA, Zelefsky MJ, Hricak H: MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer. Eur J Radiol 2013, 82(12):e775-781.CrossRef
19.
go back to reference Ishiyama H, Satoh T, Kitano M, Tabata K, Komori S, Ikeda M, Soda I, Kurosaka S, Sekiguchi A, Kimura M et al: High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up. J Radiat Res 2014, 55(3):509-517.CrossRef Ishiyama H, Satoh T, Kitano M, Tabata K, Komori S, Ikeda M, Soda I, Kurosaka S, Sekiguchi A, Kimura M et al: High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up. J Radiat Res 2014, 55(3):509-517.CrossRef
20.
go back to reference Sullivan L, Williams SG, Tai KH, Foroudi F, Cleeve L, Duchesne GM: Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol 2009, 91(2):232-236.CrossRef Sullivan L, Williams SG, Tai KH, Foroudi F, Cleeve L, Duchesne GM: Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol 2009, 91(2):232-236.CrossRef
21.
go back to reference Shoji S, Nakano M, Fujikawa H, Endo K, Hashimoto A, Tomonaga T, Terachi T, Uchida T: Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes. Int J Urol 2015, 22(11):1043-1049.CrossRef Shoji S, Nakano M, Fujikawa H, Endo K, Hashimoto A, Tomonaga T, Terachi T, Uchida T: Urethra-sparing high-intensity focused ultrasound for localized prostate cancer: Functional and oncological outcomes. Int J Urol 2015, 22(11):1043-1049.CrossRef
22.
go back to reference Hoskin PJ, Rojas AM, Bownes PJ, Lowe GJ, Ostler PJ, Bryant L: Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. Radiother Oncol 2012, 103(2):217-222.CrossRef Hoskin PJ, Rojas AM, Bownes PJ, Lowe GJ, Ostler PJ, Bryant L: Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. Radiother Oncol 2012, 103(2):217-222.CrossRef
23.
go back to reference Rodda S, Tyldesley S, Morris WJ, Keyes M, Halperin R, Pai H, McKenzie M, Duncan G, Morton G, Hamm J et al: ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2017, 98(2):286-295.CrossRef Rodda S, Tyldesley S, Morris WJ, Keyes M, Halperin R, Pai H, McKenzie M, Duncan G, Morton G, Hamm J et al: ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2017, 98(2):286-295.CrossRef
24.
go back to reference An JY, Sidana A, Holzman SA, Baiocco JA, Mehralivand S, Choyke PL, Wood BJ, Turkbey B, Pinto PA: Ruling out clinically significant prostate cancer with negative multi-parametric MRI. International urology and nephrology 2018, 50(1):7-12.CrossRef An JY, Sidana A, Holzman SA, Baiocco JA, Mehralivand S, Choyke PL, Wood BJ, Turkbey B, Pinto PA: Ruling out clinically significant prostate cancer with negative multi-parametric MRI. International urology and nephrology 2018, 50(1):7-12.CrossRef
25.
go back to reference Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, Taffel M, Moreno V, Merino MJ, Wood BJ et al: What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate. Radiology 2018, 286(1):186-195.CrossRef Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, Taffel M, Moreno V, Merino MJ, Wood BJ et al: What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate. Radiology 2018, 286(1):186-195.CrossRef
26.
go back to reference Lu AJ, Syed JS, Nguyen KA, Nawaf CB, Rosoff J, Spektor M, Levi A, Humphrey PA, Weinreb JC, Schulam PG et al: Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy. Urology 2017, 105:118-122.CrossRef Lu AJ, Syed JS, Nguyen KA, Nawaf CB, Rosoff J, Spektor M, Levi A, Humphrey PA, Weinreb JC, Schulam PG et al: Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy. Urology 2017, 105:118-122.CrossRef
Metadata
Title
Apical periurethral transition zone lesions: MRI and histology findings
Authors
Sena Tuncer
Sherif Mehralivand
Stephanie A. Harmon
Thomas Sanford
G. Thomas Brown
Lindsay S. Rowe
Maria J. Merino
Bradford J. Wood
Peter A. Pinto
Peter L. Choyke
Baris Turkbey
Publication date
01-10-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 10/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02194-x

Other articles of this Issue 10/2020

Abdominal Radiology 10/2020 Go to the issue

Classics in Abdominal Radiology

Fountain sign

Classics in Abdominal Radiology

“Corn-on-the-cob” sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.